Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews.

作者: Xīn Gào , Ben Schöttker

DOI: 10.18632/ONCOTARGET.17128

关键词:

摘要: // Xīn Gao 1,2 and Ben Schottker 1,2,3 1 Division of Clinical Epidemiology Aging Research, German Cancer Research Center, Heidelberg, Germany 2 Network University 3 Institute Health Care Social Sciences, FOM University, Essen, Correspondence to: Schottker, email: Keywords : neoplasm; oxidative stress; redox signaling; signal transduction; reactive oxygen species Received November 04, 2016 Accepted April 03, 2017 Published 16, Abstract Oxidative stress results from an imbalance the species/reactive nitrogen (ROS/RNS) production oxidants defense system. Extensive research during last decades has revealed that can mediate cancer initiation development by leading not only to molecular damage but also a disruption reduction–oxidation (redox) signaling. In order provide global overview signaling pathways, which play role in formation, we conducted systematic literature search PubMed ISI Web Science identified 185 relevant reviews published 10 years. The 20 most frequently described pathways were selected be presented this review could categorized into groups: Intracellular ROS/RNS generating organelles enzymes, transduction cascades kinases/phosphatases transcription factors. generation are mitochondria, endoplasmic reticulum peroxisomes. Enzymes, including NOX, COX, LOX NOS, prominent enzymes ROS/RNS. act as messengers transmembrane receptors trigger activation or inhibition kinases/phosphatases, such family members protein tyrosine kinases phosphatases. Furthermore, these reactions activate downstream kinase MAPK cascade, PI3K PKC. phosphatases regulate phosphorylation status factors APE1/Ref-1, HIF-1α, AP-1, Nrf2, NF-κB, p53, FOXO, STAT, β-catenin. Finally, briefly discuss prevention treatment opportunities, address further needs.

参考文章(98)
Hanna M. Leinonen, Emilia Kansanen, Petri Pölönen, Merja Heinäniemi, Anna-Liisa Levonen, Role of the Keap1-Nrf2 pathway in cancer. Advances in Cancer Research. ,vol. 122, pp. 281- 320 ,(2014) , 10.1016/B978-0-12-420117-0.00008-6
Daohong Zhou, Lijian Shao, Douglas R. Spitz, Reactive oxygen species in normal and tumor stem cells. Advances in Cancer Research. ,vol. 122, pp. 1- 67 ,(2014) , 10.1016/B978-0-12-420117-0.00001-3
Dhulfiqar Ali Abed, Melanie Goldstein, Haifa Albanyan, Huijuan Jin, Longqin Hu, Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents. Acta Pharmaceutica Sinica B. ,vol. 5, pp. 285- 299 ,(2015) , 10.1016/J.APSB.2015.05.008
Federica Vannini, Khosrow Kashfi, Niharika Nath, The dual role of iNOS in cancer. Redox biology. ,vol. 6, pp. 334- 343 ,(2015) , 10.1016/J.REDOX.2015.08.009
Jérome Bourgeais, Valérie Gouilleux-Gruart, Fabrice Gouilleux, Oxidative metabolism in cancer: A STAT affair? JAK-STAT. ,vol. 2, ,(2013) , 10.4161/JKST.25764
XIANGJIAN LUO, XINFANG YU, SUFANG LIU, QIPAN DENG, XIAOLAN LIU, SONGLING PENG, HONGDE LI, JIKAI LIU, YA CAO, The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review). Oncology Reports. ,vol. 34, pp. 547- 554 ,(2015) , 10.3892/OR.2015.4029
Tarik Regad, Targeting RTK signaling pathways in cancer Cancers. ,vol. 7, pp. 1758- 1784 ,(2015) , 10.3390/CANCERS7030860
Anand S. Bhagwat, Christopher R. Vakoc, Targeting Transcription Factors in Cancer Trends in cancer. ,vol. 1, pp. 53- 65 ,(2015) , 10.1016/J.TRECAN.2015.07.001
Shahrzad Movafagh, Sean Crook, Kim Vo, Regulation of Hypoxia‐Inducible Factor‐1a by Reactive Oxygen Species : New Developments in an Old Debate Journal of Cellular Biochemistry. ,vol. 116, pp. 696- 703 ,(2015) , 10.1002/JCB.25074
Thakur Shweta, Sarkar Bibekananda, P Cholia Ravi, Gautam Nandini, Dhiman Monisha, K Mantha Anil, None, APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions Experimental and Molecular Medicine. ,vol. 46, ,(2014) , 10.1038/EMM.2014.42